Beal, Bryony
Schutte, Aletta E.
Neuen, Brendon L.
Article History
Accepted: 26 October 2023
First Online: 10 November 2023
Compliance with Ethical Standards
:
: Authors BB and AS declare that they have no conflicts of interest. Author BLN has received fees for advisory boards, steering committee roles, scientific presentations, and travel support from AstraZeneca, Bayer, Boehringer and Ingelheim, Cambridge Healthcare Research, the Limbic, Medscape, and Janssen, with all honoraria paid to his institution. He serves as Secretariat of the SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists Consortium.
: This article does not contain any studies with human or animal subjects performed by any of the authors.